EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease

Mi Bai, Mengqiu Wu iD, Mingzhu Jiang, Jia He iD, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang iD und 5 weitere

EMBO Molecular Medicine · 2023

DOI: 10.15252/emmm.202216581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Molecular Medicine, 2023. Verfasst von Mi Bai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, State Key Laboratory of Reproductive Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Protease La, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST ¦ National Key Research and Development Program of China, Nanjing Science and Technology Development Outstanding Youth Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria comprise the central metabolic hub of cells and their imbalance plays a pathogenic role in chronic kidney disease (CKD). Here, we studied Lon protease 1 (LONP1), a major mitochondrial protease, as its role in CKD pathogenesis is unclear. LONP1 expression was decreased in human patients and mice with CKD, and tubular‐specific Lonp1 overexpression mitigated renal injury and mitochondrial dysfunction in two different models of CKD, but these outcomes were aggravated by Lonp1 deletion. These results were confirmed in renal tubular epithelial cells in vitro . Mechanistically, LONP1 downregulation caused mitochondrial accumulation of the LONP1 substrate, 3‐hydroxy‐3‐methylglutaryl‐CoA synthase 2 (HMGCS2), which disrupted mitochondrial function and further accelerated CKD progression. Finally, computer‐aided virtual screening was performed, which identified a novel LONP1 activator. Pharmacologically, the LONP1 activator attenuated renal fibrosis and mitochondrial dysfunction. Collectively, these results imply that LONP1 is a promising therapeutic target for treating CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protease LaRenal Insufficiency, ChronicAnimalsHumansMiceATP-Dependent ProteasesEpithelial CellsHydroxymethylglutaryl-CoA SynthaseKidneyMitochondriaMitochondrial Proteins

Stichwörter der Autor:innen

HMGCS2LONP1chronic kidney diseasemitochondrial dysfunction

Substanzen

ATP-Dependent ProteasesHMGCS2 protein, humanHydroxymethylglutaryl-CoA SynthaseLONP1 protein, humanMitochondrial ProteinsProtease LaHMGCS2 protein, mouseLONP1 protein, mouse

Autor:innen und Institutionen

  • Department of Nephrology, State Key Laboratory of Reproductive Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China.
  • Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai, China.
  • Renal Division, Peking University First Hospital, Beijing, China.

ORCID-Profile: Mengqiu Wu, Jia He, Lin Wang, Li Yang, Zhanjun Jia, Aihua Zhang

Förderung

  • MOST ¦ National Key Research and Development Program of China
  • Nanjing Science and Technology Development Outstanding Youth Project
  • National Natural Science Foundation of China

Zitieren

APA

Bai, M., Wu, M., Jiang, M., He, J., Deng, X., Xu, S., Fan, J., Miao, M., Wang, T., Li, Y., Yu, X., Wang, L., Zhang, Y., Huang, S., Yang, L., Jia, Z., & Zhang, A. (2023). LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.202216581

Vancouver

Bai M, Wu M, Jiang M, He J, Deng X, Xu S, et al. LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO Molecular Medicine. 2023. doi:10.15252/emmm.202216581

BibTeX
@article{Bai2023,
  author = {Bai, Mi and Wu, Mengqiu and Jiang, Mingzhu and He, Jia and Deng, Xu and Xu, Shuang and Fan, Jiaojiao and Miao, Mengqiu and Wang, Ting and Li, Yuting and Yu, Xiaowen and Wang, Lin and Zhang, Yue and Huang, Songming and Yang, Li and Jia, Zhanjun and Zhang, Aihua},
  title = {LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease},
  journal = {EMBO Molecular Medicine},
  year = {2023},
  doi = {10.15252/emmm.202216581}
}
Kostenlos starten →